<DOC>
	<DOC>NCT00563810</DOC>
	<brief_summary>This is a multiple dose study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of an investigational new drug.</brief_summary>
	<brief_title>Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029</brief_title>
	<detailed_description />
	<criteria>Men aged 18 to 45 years inclusive on study day 1. Elderly men and women aged 65 to 80 years inclusive on study day 1. Women must be postmenopausal for &gt; or = 1 year (with estradiol &lt; 25 pg/mL and an FSH &gt; 40 mIU/mL). Healthy as determined by the investigator on the basis of medical history, physical examination, vital signs, clinical laboratory test results, and 12leave electrocardiogram. Elderly subjects may have stable, nonclinically significant abnormalities on physical examination, and laboratory evaluation. Nonsmoker.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Adult</keyword>
	<keyword>Aged</keyword>
</DOC>